Galapagos signs deal with Scipher for IBD drug development

Companies will jointly validate novel IBD targets

Read on PharmaTimes

Novo Nordisk resumes late-stage haemophilia trials

Clinical trial programme resumes after safety concerns

Read on PharmaTimes

AstraZeneca ships first doses of flu vaccine

Company will manufacture over 25% more doses than previously planned

Read on PharmaTimes

UK inks further coronavirus vaccine deals

Deals agreed with Janssen and Novavax for another 90 million doses

Read on PharmaTimes

FDA accepts application for self-administered Xolair use

If approved drug would offer a more flexible option for patients

Read on PharmaTimes

1 2 3

Top of page

Industry News

Companies will jointly validate novel IBD targets.
Read More >

More Stories

News

Recent launch of several new categories of compound which include the spirocyclic β-Lactams designed...
Read More >

More Stories

Latest Tweets

Follow Us